Medicus Pharma: RBx Capital buys $750K in shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Medicus Pharma Ltd. (MDCX) shares were acquired by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari, in a private placement: 436,046 common shares on November 13, 2026, at $1.72 per share, for an aggregate purchase price of $749,999.12. The purchase was funded with RBx Capital’s working capital.
RBx Capital reported beneficial ownership of 451,909 shares, or 16.2%. Dr. Bokhari reported beneficial ownership of 538,233, or 19.1%, including shares held directly, through RBx Capital and underlying options. The reported percentages use 2,788,106 issued and outstanding shares as of November 16, 2026; Dr. Bokhari’s calculation also includes 27,500 option shares in the denominator.
Filing Explained
The amendment says RBx Capital acquired the shares for general investment purposes; the reporting persons report no current plans for the actions listed in Schedule 13D Item 4, but reserve the right to pursue them later.
Key Figures
Key Terms
beneficially owned regulatory
private placement financial
subscription agreement financial
dispositive power regulatory
pecuniary interest regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of MDCX does Raza Bokhari beneficially own?
AI-generated analysis. How Rhea-AI works. Not financial advice.